Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Zenas BioPharma Stock News

ZBIONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

Zenas BioPharma (ZBIO) Forecast

News

Earnings Zenas BioPharma (ZBIO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Zenas BioPharma Stock News | NASDAQ:ZBIO | Benzinga

Get the latest news on Zenas BioPharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Zenas BioPharma performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, March 20, 2025

Zenas BioPharma Gains Outperform Rating From Analyst As Key Autoimmune Trials Progress
Vandana Singh
Wedbush Initiates Coverage On Zenas BioPharma...
Benzinga Newsdesk

Wednesday, March 12, 2025

Guggenheim Reiterates Buy on Zenas BioPharma,...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Zenas B...
Benzinga Newsdesk

Wednesday, February 05, 2025

Zenas BioPharma Reports Strong 2024 Momentum,...
Benzinga Newsdesk

Tuesday, February 04, 2025

Wolfe Research Initiates Coverage On Zenas Bi...
Benzinga Newsdesk

Wednesday, January 22, 2025

Progress Software, Disc Medicine And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor

Monday, December 16, 2024

This Addus HomeCare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Avi Kapoor
HC Wainwright & Co. Initiates Coverage On Zen...
Benzinga Newsdesk

Wednesday, December 11, 2024

Visa To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Morgan Stanley Maintains Overweight on Zenas ...
Benzinga Newsdesk

Tuesday, December 03, 2024

Guggenheim Reiterates Buy on Zenas BioPharma
Benzinga Newsdesk

Tuesday, November 12, 2024

Zenas BioPharma Completes Targeted Enrollment...
Benzinga Newsdesk

Friday, October 25, 2024

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights

Tuesday, October 08, 2024

Citigroup Initiates Coverage On Zenas BioPhar...
Benzinga Newsdesk
Jefferies Initiates Coverage On Zenas BioPhar...
Benzinga Newsdesk
Morgan Stanley Initiates Coverage On Zenas Bi...
Benzinga Newsdesk
Guggenheim Initiates Coverage On Zenas BioPha...
Benzinga Newsdesk

Friday, September 13, 2024

Zenas BioPharma IPO Shares Open For Trade At ...
Benzinga Newsdesk
Trading Halt: Halt status updated at 10:35:00...
Benzinga Newsdesk
Reported Earlier, Zenas BioPharma Prices Upsi...
Benzinga Newsdesk

Thursday, September 12, 2024

Zenas Biopharma, Inc IPOs Tomorrow, Here's What You Need To Know
Benzinga Insights

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved